Cargando…

Perspectives of Genome-Editing Technologies for HIV Therapy

Background: Current HIV antiretroviral therapies potently suppress virus replication and prevent patients from progressing to AIDS but are unable to completely eliminate HIV due to the existence of dormant viral reservoirs which threaten to reemerge at anytime. Recently, genome-editing technologies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebina, Hirotaka, Gee, Peter, Koyanagi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384355/
https://www.ncbi.nlm.nih.gov/pubmed/26255882
http://dx.doi.org/10.2174/1570162X13666150807105718
_version_ 1782520449788280832
author Ebina, Hirotaka
Gee, Peter
Koyanagi, Yoshio
author_facet Ebina, Hirotaka
Gee, Peter
Koyanagi, Yoshio
author_sort Ebina, Hirotaka
collection PubMed
description Background: Current HIV antiretroviral therapies potently suppress virus replication and prevent patients from progressing to AIDS but are unable to completely eliminate HIV due to the existence of dormant viral reservoirs which threaten to reemerge at anytime. Recently, genome-editing technologies that can recognize specific DNA sequences, including viral DNA, are being touted as promising tools for curing HIV, owing to their specificity, ease of use, and ability to be custom designed. Conclusion: Here, we introduce several novel strategies aimed at eradicating HIV proviruses with state-of-the-art genome-editing technologies and discuss perspectives of these approaches for curing HIV.
format Online
Article
Text
id pubmed-5384355
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-53843552017-04-12 Perspectives of Genome-Editing Technologies for HIV Therapy Ebina, Hirotaka Gee, Peter Koyanagi, Yoshio Curr HIV Res Article Background: Current HIV antiretroviral therapies potently suppress virus replication and prevent patients from progressing to AIDS but are unable to completely eliminate HIV due to the existence of dormant viral reservoirs which threaten to reemerge at anytime. Recently, genome-editing technologies that can recognize specific DNA sequences, including viral DNA, are being touted as promising tools for curing HIV, owing to their specificity, ease of use, and ability to be custom designed. Conclusion: Here, we introduce several novel strategies aimed at eradicating HIV proviruses with state-of-the-art genome-editing technologies and discuss perspectives of these approaches for curing HIV. Bentham Science Publishers 2016-01 2016-01 /pmc/articles/PMC5384355/ /pubmed/26255882 http://dx.doi.org/10.2174/1570162X13666150807105718 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Ebina, Hirotaka
Gee, Peter
Koyanagi, Yoshio
Perspectives of Genome-Editing Technologies for HIV Therapy
title Perspectives of Genome-Editing Technologies for HIV Therapy
title_full Perspectives of Genome-Editing Technologies for HIV Therapy
title_fullStr Perspectives of Genome-Editing Technologies for HIV Therapy
title_full_unstemmed Perspectives of Genome-Editing Technologies for HIV Therapy
title_short Perspectives of Genome-Editing Technologies for HIV Therapy
title_sort perspectives of genome-editing technologies for hiv therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384355/
https://www.ncbi.nlm.nih.gov/pubmed/26255882
http://dx.doi.org/10.2174/1570162X13666150807105718
work_keys_str_mv AT ebinahirotaka perspectivesofgenomeeditingtechnologiesforhivtherapy
AT geepeter perspectivesofgenomeeditingtechnologiesforhivtherapy
AT koyanagiyoshio perspectivesofgenomeeditingtechnologiesforhivtherapy